[GRAPHICS]
trans-RuCL2[(R)-xylbinap][(R)-daipen] or the S,S complex acts as an efficie
nt catalyst for asymmetric hydrogenation of hetero-aromatic ketones. The hy
drogenation proceeds with a substrate-to-catalyst molar ratio of 1000-40000
to give chiral alcohols in high ee and high yield. The enantioselectivity
appears to be little affected by the properties of the hetero-aromatic ring
. This method allows for asymmetric synthesis of duloxetine, an inhibitor o
f serotonin and norepinephrine uptake carriers.